Wuxi Pharmatech (cayman) Inc.
A maker of outsourced research and manufacturing services for the drug industry, WuXi helps pharmaceutical and biotech companies test and produce new medicines and medical devices. It began in 2000 as a small Shanghai chemistry lab founded by organic chemist Ge Li and partners, and took on the "AppTec" part of its name after buying a U.S. testing firm in 2008. Its "WuXi" name honors the Chinese city of Wuxi, where the founder hails from and where it built early operations.
Sponsored ADR (each ADS represents 8 ordinary shares) — Taken private Dec 10, 2015 via .3B merger; delisted from NYSE.
No insider transactions reported in the last 3 years. Look across all recorded history →